6 Fanconi Anemia Clinical Trials in Denver, CO (2026)

Q: How do I join a clinical trial in Denver?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you.

Recruiting Fanconi Anemia Studies in Denver

NCT05838690Recruiting

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

The purpose of the study is to assess the impact of a personalized intubation planning tool, the Personalized INtubation Safety (PINS) Bundle on intubation procedural safety and clinical outcomes amon...

Denver, CO3,000 participantsChildren's Hospital of Philadelphia

View Study Details

NCT05650658Recruiting

Left vs Left Randomized Clinical Trial

The investigators aim to prospectively test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failur...

Denver, CO2,136 participantsBaylor College of Medicine

View Study Details

NCT05933083Recruiting

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do n...

Denver, CO516 participantsUniversity of California, San Francisco

View Study Details

NCT04787042Recruiting

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

Denver, CO316 participantsSimcha IL-18, Inc.

View Study Details

NCT07038200Recruiting

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)...

Denver, CO200 participantsAvidity Biosciences, Inc.

View Study Details

NCT07435662Recruiting

Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver

Numerous pharmacotherapies have been proven to reduce mortality and hospitalization rates for heart failure with reduced ejection fraction (HFrEF) patients. However, these are underutilized clinically...

Denver, CO40 participantsDenver Health and Hospital Authority

View Study Details

About Fanconi Anemia Clinical Trials in Denver

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 6 fanconi anemia clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 6,208 participants. Research is being sponsored by Children's Hospital of Philadelphia, Baylor College of Medicine, University of California, San Francisco and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Denver — FAQ

Are there fanconi anemia clinical trials in Denver?

Yes, there are 6 fanconi anemia clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Denver?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.

Are clinical trials in Denver free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 6 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov